Harvard Bioscience (HBIO) Liabilities from Discontinued Operations (2017)
Harvard Bioscience (HBIO) reported Liabilities from Discontinued Operations of 1311000.0 for Q4 2017.
Harvard Bioscience (HBIO) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 1311000.0 in Q4 2017.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 1311000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was 1311000.0 (changed N/A YoY) and the FY2017 annual result came in at 1311000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations steadied at 1311000.0 in Q4 2017 per HBIO's latest filing.
- Across five years, Liabilities from Discontinued Operations topped out at 1311000.0 in Q4 2017 and bottomed at 1311000.0 in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 1.31 Mn |
| Dec 31, 2017 | 1.31 Mn |